According to Boston Scientific, the study, ‘Holmium Laser Lithotripsy Under Direct Cholangioscopic Guidance in Complicated Stone Cases: Long Term Experience,’ led by Bryan G Sauer, found that laser lithotripsy using the Holmium laser under cholangioscopic guidance is safe and effective for treating complex biliary stones.

The study, ‘SpyGlass Peroral Cholangioscopy System for Visual Differentiation and Optically Guided Tissue Sample Biopsy of Biliary Strictures: A Single-Center Preliminary Observational Study,’ led by Dimitrios Xinopoulo, found that the SpyGlass System is a useful diagnostic tool when dealing with radiologically evident biliary strictures, and that tissue sampling under visual control is technically feasible and clinically safe.

The study, ‘Cholangioscopic Characterization of Dominant Biliary Strictures in Patients With Primary Sclerosing Cholangitis (PSC) May Not Be Indicative of Malignancy,’ led by Kalpesh K Patel, demonstrated that dominant biliary strictures in PSC patients can be successfully visualized with the SpyGlass System, and adequate tissue can be acquired for biopsy sampling.

According to Boston Scientific, the studies featuring Radial Jaw 4 include: A Novel Biopsy Protocol for Assessment of Neosquamous Epithelium After Radiofrequency Ablation of Barrett’s Esophagus With High Grade Dysplasia (Poster Presentation featuring ), led by Srinadh Komanduri, found that tissue acquisition with jumbo biopsy forceps facilitates assessment for buried glands after radiofrequency ablation.

The study, ‘Randomized Controlled Trial of Two Types of Biopsy Forceps for Polypectomy of Small Sessile Colorectal Polyps,’ led by Peter Draganov, demonstrated that Radial Jaw 4 Forceps are more effective for complete eradication of small sessile colorectal polyps than Radial Jaw 3 forceps.

The study, ‘The Utility of New Jumbo Biopsy Forceps for Tissue Acquisition of Gastric Subepithelial Masses, led by Srinadh Komanduri,’ demonstrated the efficacy and safety of jumbo biopsy forceps in obtaining diagnostic tissue in gastric subepithelial masses, resulting in cost savings by reducing unnecessary referrals for endoscopic ultrasound and endoscopic surveillance.

Michael Phalen, senior vice president, and president of Boston Scientific’s Endoscopy Division, said: “The large number of studies at DDW evaluating Boston Scientific technologies highlights our commitment to advancing the field of endoscopy for diseases throughout the GI tract.”